Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis

Purpose: Drug interactions are a concern in oncology with the shift toward oral antineoplastics (OAs). Using electronic databases to screen for drug interactions with OAs is a common practice. There is little literature to guide clinicians on the reliability of these systems with OAs. The primary ob...

Full description

Bibliographic Details
Main Authors: Bossaer, John B., Thomas, Christan M.
Published: Digital Commons @ East Tennessee State University 2017
Subjects:
OAs
Online Access:https://dc.etsu.edu/etsu-works/2328
https://doi.org/10.1200/JOP.2016.016212
id ndltd-ETSU-oai-dc.etsu.edu-etsu-works-3417
record_format oai_dc
spelling ndltd-ETSU-oai-dc.etsu.edu-etsu-works-34172019-05-16T05:04:41Z Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis Bossaer, John B. Thomas, Christan M. Purpose: Drug interactions are a concern in oncology with the shift toward oral antineoplastics (OAs). Using electronic databases to screen for drug interactions with OAs is a common practice. There is little literature to guide clinicians on the reliability of these systems with OAs. The primary objective of this study was to explore the sensitivity of commonly available drug interaction databases in detecting drug interactions with OAs. Methods: A list of 20 drug interactions with OAs was developed by two Board-certified oncology pharmacists. The list included multiple types of drug interactions. The sensitivity in detecting these interactions by MicroMedex, Facts & Comparisons, Lexi-Interact, and Epocrates were evaluated. These databases were chosen based on their local availability and widespread use in practice. Drugs.com was evaluated as a surrogate for a patient-accessible drug interaction database. The Cochran Q test was used to assess the sensitivity distribution across the five groups. Results: Lexi-Interact and Drugs.com had a sensitivity of 95% for the 20 tested drug interaction pairs. Epocrates had a sensitivity of 90%, and both Micromedex and Facts & Comparisons had a sensitivity of 70%. There was a statistically significant difference (P = .016) in the distribution across the databases in detecting clinically significant drug interactions. Conclusion: Commonly used databases for identifying drug interactions with oral antineoplastics vary significantly in their sensitivity. Clinicians should not rely on a single database and should consider using multiple resources as well as sound clinical judgment. Further work is needed in this area. 2017-01-17T08:00:00Z text https://dc.etsu.edu/etsu-works/2328 https://doi.org/10.1200/JOP.2016.016212 ETSU Faculty Works Digital Commons @ East Tennessee State University oncology analysis drug interaction pharmacology database sensitivity OAs oral antineoplastics Pharmacy Practice Pharmacy and Pharmaceutical Sciences
collection NDLTD
sources NDLTD
topic oncology
analysis
drug interaction
pharmacology
database sensitivity
OAs
oral antineoplastics
Pharmacy Practice
Pharmacy and Pharmaceutical Sciences
spellingShingle oncology
analysis
drug interaction
pharmacology
database sensitivity
OAs
oral antineoplastics
Pharmacy Practice
Pharmacy and Pharmaceutical Sciences
Bossaer, John B.
Thomas, Christan M.
Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
description Purpose: Drug interactions are a concern in oncology with the shift toward oral antineoplastics (OAs). Using electronic databases to screen for drug interactions with OAs is a common practice. There is little literature to guide clinicians on the reliability of these systems with OAs. The primary objective of this study was to explore the sensitivity of commonly available drug interaction databases in detecting drug interactions with OAs. Methods: A list of 20 drug interactions with OAs was developed by two Board-certified oncology pharmacists. The list included multiple types of drug interactions. The sensitivity in detecting these interactions by MicroMedex, Facts & Comparisons, Lexi-Interact, and Epocrates were evaluated. These databases were chosen based on their local availability and widespread use in practice. Drugs.com was evaluated as a surrogate for a patient-accessible drug interaction database. The Cochran Q test was used to assess the sensitivity distribution across the five groups. Results: Lexi-Interact and Drugs.com had a sensitivity of 95% for the 20 tested drug interaction pairs. Epocrates had a sensitivity of 90%, and both Micromedex and Facts & Comparisons had a sensitivity of 70%. There was a statistically significant difference (P = .016) in the distribution across the databases in detecting clinically significant drug interactions. Conclusion: Commonly used databases for identifying drug interactions with oral antineoplastics vary significantly in their sensitivity. Clinicians should not rely on a single database and should consider using multiple resources as well as sound clinical judgment. Further work is needed in this area.
author Bossaer, John B.
Thomas, Christan M.
author_facet Bossaer, John B.
Thomas, Christan M.
author_sort Bossaer, John B.
title Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
title_short Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
title_full Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
title_fullStr Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
title_full_unstemmed Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
title_sort drug interaction database sensitivity with oral antineoplastics: an exploratory analysis
publisher Digital Commons @ East Tennessee State University
publishDate 2017
url https://dc.etsu.edu/etsu-works/2328
https://doi.org/10.1200/JOP.2016.016212
work_keys_str_mv AT bossaerjohnb druginteractiondatabasesensitivitywithoralantineoplasticsanexploratoryanalysis
AT thomaschristanm druginteractiondatabasesensitivitywithoralantineoplasticsanexploratoryanalysis
_version_ 1719189423440003072